Joseph Sassani, M.D., Penn State Hershey Department of Ophthalmology
Researchers at Penn State Milton S. Hershey Medical Center are determining the safety of eye drops containing Naltrexone, a medication that may facilitate corneal wound healing and which is approved by the U.S. Food and Drug Administration to be taken internally. The Naltrexone eye drops will be applied for one day to one eye of healthy volunteers.
You may be eligible if you:
are from 21 to 50 years old.
have not had corneal or other surface disease.
do not have systemic disease associated with surface complications including autoimmune or rheumatologic disorders or diabetes.
Additional Study Details:
Compensation is provided.
Penn State Milton S. Hershey Medical Center, Penn State Hershey Department of Ophthalmology
To see if you are eligible, contact Susan Chobanoff at 717-531-3790.
Study director: Joseph Sassani, M.D., Penn State Hershey Department of Ophthalmology